# Sohag University

Organization · id `cardio:org-sohag-university` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ROR record 02wgx3e98](<https://ror.org/02wgx3e98>), retrieved 18 November 2026. No person wrote or checked this page.

## In plain language

An organization that ClinicalTrials.gov lists as a sponsor or collaborator of 3 trials in this atlas.

## Technical summary

Sponsor class other. Matched to ROR record 02wgx3e98 by an exact name.

## The registry's words

- Sponsor name: Sohag University
- Sponsor class: OTHER
- ROR name: Sohag University

## Connected pages

- Sponsors: Ombitasvir/ Paritaprevir / Ritonavir Plus Ribavirin in Management HCV and End-stage Kidney Disease (`cardio:ct-nct03499639`)
- Sponsors: Correlation Between Endoscopic Findings And Helicobacter Pylori Infection In Chronic Kidney Disease Patients (`cardio:ct-nct05927766`)
- Sponsors: The Impact Of SGLT2 -I on Metabolic Dysfunction -Associated Steatotic Liver Disease In Patients With Type 2 Diabetes Mellitus (`cardio:ct-nct06117137`)

## Provenance

Content hash: cb8658a7ab71f1fbb5d8237982fa1a0870ce4dee3ac3e9076e6296beb69de921
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
